Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of KK2269 in Adult Participants With Solid Tumors [Phase 1]
Phase 1 study update for KK2269 in adults with solid tumors; the trial is currently recruiting. Indications include gastric adenocarcinoma, …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma [Phase 3]
Clinical trial update for ASKB589 in combination with CAPOX and a PD-1 inhibitor for advanced or metastatic gastric/gastroesophageal junctio…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer [Phase 1, Phase 2]
Bolt Biotherapeutics is conducting a first-in-human Phase 1/2 study of BDC-4182 as a single-agent therapy in metastatic gastric adenocarcino…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer [Phase 2, Phase 3]
A perioperative trial investigating the combination of SOX chemotherapy with Apatinib and Camrelizumab for gastric and gastroesophageal junc…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2) [Phase 2]
A Phase 2 trial (VIKTORY-2) is evaluating the combination of savolitinib and durvalumab in MET-amplified advanced gastric cancer and is curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma [Phase 2]
A Phase 2 neoadjuvant trial evaluating intra-tumoral RP2 in combination with the FLOT regimen for gastric and esophageal adenocarcinoma is l…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating Fruquintinib in combination with Trastuzumab and XELOX as first-line thera…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers [NA]
A completed clinical trial study examined determinants of patient delay in seeking medical consultation for esophageal cancer and gastric ad…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer [Phase 3]
A Phase 3 trial comparing surgical resection plus chemotherapy versus chemotherapy alone for oligometastatic stage IV gastric cancer has bee…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer [Phase 2]
Phase II trial (RAINSPOT) evaluating zolbetuximab combined with paclitaxel and ramucirumab in CLDN18.2-positive gastric and gastroesophageal…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis [Phase 1]
This is a Phase 1 clinical trial evaluating Aldesleukin in combination with Nivolumab and standard chemotherapy for clinical stage IV gastri…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma [Phase 1]
Phase Ib trial evaluating the safety and activity of neoadjuvant tislelizumab plus the FLOT chemotherapy regimen in patients with resectable…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) [Phase 1, Phase 2]
A Roche-sponsored Phase 1/2 clinical trial evaluating multiple immunotherapy-based treatment combinations in patients with locally advanced …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy [Phase 3]
The PREACT Phase 3 trial comparing chemoradiotherapy versus chemotherapy followed by D2 gastrectomy and adjuvant chemotherapy for locally ad…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma
Completed clinical trial update reporting biomarker analysis for the tislelizumab-chemotherapy combination as perioperative treatment for ga…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer [Phase 2]
A Phase II multicenter randomized trial is evaluating sintilimab plus SOX versus SOX alone as adjuvant therapy for PD-L1-positive, stage pN3…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors [Phase 1]
A Phase I trial of JS004, a recombinant humanized anti-BTLA monoclonal antibody, in combination with toripalimab for advanced solid tumors h…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating paclitaxel, pembrolizumab, and olaparib in previously treated advanced gastric adenocarcinoma is currently…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]
This is a Phase 2 randomized study evaluating serplulimab in combination with chemotherapy for locally advanced gastric cancer (gastric aden…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]
Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multip…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab [Phase 2]
A Phase 2 basket trial evaluating the combination of niraparib and dostarlimab across multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab combined with XELOX as neoadjuvant therapy for locally advanced gastric or gastroesophageal junction a…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating Ivonescimab in combination with chemotherapy for advanced or metastatic gastric/gastroesophageal adenocarc…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.